Advantages of the Net Benefit Regression Framework for Trial-Based Economic Evaluations of Cancer Treatments: An Example From the Canadian Cancer Trials Group CO.17 Trial

BMC Cancer - United Kingdom
doi 10.1186/s12885-019-5779-x

Related search